July 11, 2013 — The U.S. Food and Drug Administration (FDA) has cleared the Siemens Healthcare’s Mammomat T Inspiration Prime Edition, which lowers patient radiation dose up to 30 percent without compromising image quality. The Mammomat Inspiration Prime Edition lowers dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction. Capable of identifying scatter-causing structures and calculating a corrected image, this new algorithm potentially enables complete use of primary radiation so physicians can achieve high-quality images using less dose.
Siemens’ new reconstruction algorithm for the Mammomat Inspiration system – known as Prime (Progressive Reconstruction, Intelligently Minimizing Exposure) – eliminates the need for the scatter radiation grid of conventional mammography systems. The Prime algorithm corrects the scattered radiation by identifying scatter-causing structures and recalculating the image, leaving intact the primary radiation upon which radiologists rely. For this reason, the design of the Mammomat Inspiration Prime Edition obviates the need for a grid, and lower patient doses are sufficient to generate high-quality breast images. The grid-free imaging technology of the Mammomat Inspiration Prime Edition reduces dose up to 30 percent compared to its predecessor model, depending on the thickness of the patient’s breast tissue.
The Mammomat Inspiration Prime Edition is based on the modular Mammomat Inspiration platform for screening, diagnostics, and biopsy, which has been used by hospitals and physicians offices since 2007.
For further information: www.siemens.com/healthcare
May 10, 2024 
